Literature DB >> 20406770

Feasibility of 64-slice gadolinium-enhanced cardiac CT for the evaluation of obstructive coronary artery disease.

Patricia Carrascosa1, Carlos Capuñay, Alejandro Deviggiano, Marcelo Bettinotti, Alejandro Goldsmit, Carlos Tajer, Jorge Carrascosa, Mario J García.   

Abstract

OBJECTIVE: To assess the feasibility of gadolinium-enhanced 64-slice cardiac CT (CCT) for the diagnosis of obstructive coronary artery disease.
DESIGN: Comparative prospective study.
SETTING: Outpatient Imaging Diagnostic Centre, Diagnóstico Maipú, Buenos Aires, Argentina. PATIENTS: Twenty patients with suspected coronary artery disease.
INTERVENTIONS: Gadolinium-enhanced 64-slice CCT was performed before invasive coronary angiography (ICA). MAIN OUTCOME MEASURES: The feasibility of gadolinium-enhanced 64-slice CCT for detection of obstructive coronary artery disease (>50% diameter reduction) was evaluated, using ICA as the 'gold standard'. Mean lumen attenuation, non-calcified and calcified plaques densities were correlated between gadolinium-enhanced CCT studies and iodine-enhanced CCT studies of a control group. Renal function was strictly monitored.
RESULTS: Gadolinium-enhanced CCT demonstrated adequate visualisation of 283/289 coronary segments that were evaluable by ICA, 31 of which had >50% luminal stenosis. In per-segment analysis, gadolinium-enhanced CCT showed a sensitivity of 90.3%, specificity of 96.8%, positive predictive value of 77.8% and negative predictive value of 98.8%. The agreement of coronary stenosis between multidetector CT (MDCT) and ICA was 94.1% (272/289). The mean lumen attenuation, non-calcified and calcified plaques densities in gadolinium-enhanced CCT studies were 140.1 Hounsfield units (HU), 51.1 HU and 523.6 HU, whereas in iodine-enhanced CCT studies the values were 354.1 HU, 101.0 HU and 778.5 HU, respectively (p < 0.001).
CONCLUSION: Gadolinium-enhanced CCT is a feasible alternative for patients with severe contraindications to iodinated contrast agents referred for MDCT coronary angiography.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20406770     DOI: 10.1136/hrt.2009.183699

Source DB:  PubMed          Journal:  Heart        ISSN: 1355-6037            Impact factor:   5.994


  7 in total

1.  Methodological quality of diagnostic accuracy studies on non-invasive coronary CT angiography: influence of QUADAS (Quality Assessment of Diagnostic Accuracy Studies included in systematic reviews) items on sensitivity and specificity.

Authors:  Sabine Schueler; Stefan Walther; Georg M Schuetz; Peter Schlattmann; Marc Dewey
Journal:  Eur Radiol       Date:  2013-01-16       Impact factor: 5.315

Review 2.  Nanoparticle contrast agents for X-ray imaging applications.

Authors:  Jessica C Hsu; Lenitza M Nieves; Oshra Betzer; Tamar Sadan; Peter B Noël; Rachela Popovtzer; David P Cormode
Journal:  Wiley Interdiscip Rev Nanomed Nanobiotechnol       Date:  2020-05-22

3.  Feasibility of gadolinium-enhanced dual energy CT pulmonary angiography: a pilot study in rabbits.

Authors:  Long Jiang Zhang; Zhen Jane Wang; Li Lu; Bo Chen; Guang Ming Lu
Journal:  Int J Cardiovasc Imaging       Date:  2010-11-26       Impact factor: 2.357

Review 4.  Nanoparticle contrast agents for computed tomography: a focus on micelles.

Authors:  David P Cormode; Pratap C Naha; Zahi A Fayad
Journal:  Contrast Media Mol Imaging       Date:  2014 Jan-Feb       Impact factor: 3.161

Review 5.  Use of 3x2 tables with an intention to diagnose approach to assess clinical performance of diagnostic tests: meta-analytical evaluation of coronary CT angiography studies.

Authors:  Georg M Schuetz; Peter Schlattmann; Marc Dewey
Journal:  BMJ       Date:  2012-10-24

6.  A Library of Potential Nanoparticle Contrast Agents for X-Ray Fluorescence Tomography Bioimaging.

Authors:  Yuyang Li; Kian Shaker; Jakob C Larsson; Carmen Vogt; Hans M Hertz; Muhammet S Toprak
Journal:  Contrast Media Mol Imaging       Date:  2018-12-27       Impact factor: 3.161

7.  Gold-coated plant virus as computed tomography imaging contrast agent.

Authors:  Alaa A A Aljabali; Mazhar S Al Zoubi; Khalid M Al-Batanyeh; Ali Al-Radaideh; Mohammad A Obeid; Abeer Al Sharabi; Walhan Alshaer; Bayan AbuFares; Tasnim Al-Zanati; Murtaza M Tambuwala; Naveed Akbar; David J Evans
Journal:  Beilstein J Nanotechnol       Date:  2019-10-07       Impact factor: 3.649

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.